Company Seeks To Enjoin FDA From Restricting Speech About Off-Label Uses
NEW YORK — On the heels of a ruling in a similar case, Pacira Pharmaceuticals Inc. on Sept. 8 filed a declaratory action seeking to enjoin the Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article